|
|
News Breaks | | | | January 14, 2013 | | 06:38 EDT |  | MDRX | Allscripts upgraded to Strong Buy from Market Perform at Raymond James
Raymond James upgraded Allscripts due to expectations for stable Q4 earnings results, new management catalysts, new product launches, and valuation. Price target is $13. | |
|
News For MDRX From The Last 14 Days Check below for free stories on MDRX the last two weeks. |
|
|
| May 23, 2013 | | 09:39 EDT |  | MDRX | Allscripts downgraded to Outperform from Strong Buy at Raymond James
 Subscribe for More Information | | | May 14, 2013 | | 10:01 EDT | | MDRX | On The Fly: Analyst Upgrade Summary
Subscribe for More Information | | | 05:36 EDT | | MDRX | Allscripts upgraded to Buy from Neutral at Citigroup
Subscribe for More Information | | | May 9, 2013 | | 18:52 EDT |  | MDRX | On The Fly: After Hours Movers
UP AFTER EARNINGS: Ubiquiti Networks (UBNT), up 11.6%... Unilife (UNIS), up 10.8%... Sequenom (SQNM), up 9.8%. DOWN AFTER EARNINGS: priceline.com (PCLN), down 3.2%... Allscripts (MDRX), down 6.1%... Air Lease (AL), down 10%. ALSO LOWER: Affymax (AFFY), down 11% after disclosing in a regulatory filing that its financial position may prevent it from continuing operations... Discovery Labs (DSCO), down 8.5% after filing to sell common stock... magicJack (CALL), down 6.4% after naming a new CFO. | | | 16:08 EDT |  | MDRX | Allscripts reports Q1 EPS 9c, consensus 14c
Subscribe for More Information | |
|
|
|
|
|
|
